Equipped with advanced infrastructure, comprising three clinical units with 150 beds located in specialised hospitals, Ecron Acunova conducts PK/PD studies with healthy volunteers for the generic industry.
Recorded as the largest study was a 120-volunteer study conducted till date. An independent Central Ethics Committee reviews the study. Volunteers screening tests are done in our CAP-certified lab. A library of validated methods is available in several indications. A sophisticated analytical lab analyses the samples in a wide range of matrices on a bank of HPLC, LCMS/MS. Pivotal studies have been conducted for submission to Health Canada, EU, DCGI, MHRA, US FDA, and WHO.Studies have been audited by regulators including US FDA and WHO.
For more information, please see our website.